FDA Person
Office of the CommissionerJoseph R. Lambert
View detailed information about Joseph R. Lambert, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of the Commissioner.
Documents (12)
- 483 · Haleon US Inc. · July 8, 2011
- WARNING LETTER · Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd. · October 20, 2017
- WARNING LETTER · Wuxi Medical lnstrument Factory Co., Ltd. · November 15, 2024
- WARNING LETTER · Bioiberica, SAU · February 4, 2022
- 483 · Hillandale Iowa II LLP · August 26, 2010
- 483 · Nebraska Methodist Hospital · December 18, 2015
- 483 · Haleon US Inc. · February 14, 2013
- 483 · Essential Pharmacy Compounding · May 22, 2015
- EIR · Hospira, Inc., A Pfizer Company · May 25, 2012
- EIR · Mylan Laboratories Limited · June 26, 2024
- EIR · ProPharma Group, LLC DBA PI ARM · July 15, 2015
- EIR · Unknown Company · June 26, 2024
Related Office
Person Information
Name
Joseph R. Lambert
Title
Compliance Officer, CDER, Office of Manufacturing
Role
Regulatory Personnel
ID: d2968fda-8e5e-433a-b60b-f68aaef3b7b0
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.